488 related articles for article (PubMed ID: 1676547)
1. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
2. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
3. A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.
Yang SY; Denning SM; Mizuno S; Dupont B; Haynes BF
J Exp Med; 1988 Oct; 168(4):1457-68. PubMed ID: 3049912
[TBL] [Abstract][Full Text] [Related]
4. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
5. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
June CH; Ledbetter JA; Lindsten T; Thompson CB
J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
[TBL] [Abstract][Full Text] [Related]
7. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
8. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Yang SY; Rhee S; Welte K; Dupont B
J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
[TBL] [Abstract][Full Text] [Related]
9. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
10. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
11. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Koulova L; Yang SY; Dupont B
J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
[TBL] [Abstract][Full Text] [Related]
12. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
13. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
Costello R; Brailly H; Mallet F; Mawas C; Olive D
Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
[TBL] [Abstract][Full Text] [Related]
15. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
June CH; Ledbetter JA; Gillespie MM; Lindsten T; Thompson CB
Mol Cell Biol; 1987 Dec; 7(12):4472-81. PubMed ID: 2830495
[TBL] [Abstract][Full Text] [Related]
16. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
[TBL] [Abstract][Full Text] [Related]
17. Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions.
Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
Scand J Immunol; 1988 Sep; 28(3):277-84. PubMed ID: 2461580
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
19. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
20. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]